Serum Periostin as a Novel Biomarker for Predicting 30-Day Major Adverse Cardiac Events After Off-Pump Coronary Artery Bypass Grafting

Authors

Institutions

Publication Details

Journal
Therapeutics and Clinical Risk Management
Published
2025-02-01
DOI
https://doi.org/10.2147/tcrm.s507435
Citations
1
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
1.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum Periostin as a Novel Biomarker for Predicting 30-Day Major Adverse Cardiac Events After Off-Pump Coronary Artery Bypass Grafting

Xiangqing Wei, Jie Song, Zhipeng Deng, Lei Yao et al.
1 citations
Therapeutics and Clinical Risk Management
Cardiac Valve Diseases and Treatments
1.39
article

Serum Periostin as a Novel Biomarker for Predicting 30-Day Major Adverse Cardiac Events After Off-Pump Coronary Artery Bypass Grafting

Xiangqing Wei, Jie Song, Zhipeng Deng, Lei Yao, Q. Y. Su, Fei Guo, Lu Li, Boxiang Du, Yi Gu
article en
1 citations

Abstract

No abstract available for this paper.
Therapeutics and Clinical Risk ManagementVol. Volume 21
Nantong University (CN), Affiliated Hospital of Nantong University (CN)
Good health and well-being
Openalex Percentile: Top 23%
Cardiac Valve Diseases and Treatments
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Serum Periostin as a Novel Biomarker for Predicting 30-Day Major Adverse Cardiac Events After Off-Pump Coronary Artery Bypass Grafting — Xiangqing Wei, Jie Song, et al. · Therapeutics and Clinical Risk Management (2025) | TGRS Research Map | TGRS